Millennium Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-100,000
Closed -$16.7M 4744
2019
Q2
$16.7M Buy
100,000
+50,000
+100% +$6.92M 0.03% 894
2019
Q1
$7.32M Buy
+50,000
New +$7.25M 0.01% 1497
2018
Q3
Sell
-110,000
Closed -$18.3M 4473
2018
Q2
$18.3M Buy
+110,000
New +$17.7M 0.02% 914
2015
Q2
Sell
-50,000
Closed -$14.9M 4043
2015
Q1
$14.9M Buy
50,000
+10,000
+25% +$2.85M 0.03% 829
2014
Q4
$10.3M Sell
40,000
-25,000
-38% -$6.25M 0.02% 971
2014
Q3
$15.7M Buy
65,000
+25,000
+63% +$5.59M 0.04% 616
2014
Q2
$8.92M Sell
40,000
-6,100
-13% -$1.26M 0.02% 882
2014
Q1
$9.49M Sell
46,100
-94,900
-67% -$18.8M 0.03% 841
2013
Q4
$23.7M Sell
141,000
-39,000
-22% -$6.1M 0.07% 287
2013
Q3
$25.9M Buy
+180,000
New +$24M 0.08% 255

Other funds holding AGN

Millennium Management's AGN Position: Q2 2020 in Review

Millennium Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,869,196 shares — an estimated $685M sold.

Millennium Management first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $685M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Millennium Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Millennium Management sold 3,869,196 Allergan plc shares in Q2 2020, an estimated $685M.
  • Millennium Management first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Millennium Management's Allergan plc position peaked at $685M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Millennium Management's 13F filing for Q2 2020, filed 14 Aug 2020.